Pnc Financial Services Group, Inc. Hepion Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.31 - $1.06 $18 - $63	-60 Reduced 0.1%	57,534 $44,000
Q4 2022 Feb 10, 2023	BUY	$0.27 - $11.9 $16 - $714	60 Added 0.1%	57,594 $17,000
Q4 2021 Feb 11, 2022	BUY	$1.14 - $1.58 $21,090 - $29,230	18,500 Added 47.39%	57,534 $65,000
Q3 2021 Nov 05, 2021	BUY	$1.39 - $2.1 $54,257 - $81,971	39,034 New	39,034 $59,000
Q4 2019 Feb 07, 2020	SELL	$2.25 - $6.99 $65 - $202	-29 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$2.09 - $4.12 $60 - $119	29 New	29 $0

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.